MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1701 to 1720 of 166,322 approvalsPage 86 of 8317

Phloroglucinol Orally Disintegrating Tablets

Approval Number: 国药准字H20253134
Registration: Jan 14, 2025

Formoterol fumarate Inhalation Solution

Approval Number: 国药准字H20253219
Registration: Jan 14, 2025

Etoricoxib Tablets

Approval Number: 国药准字H20253146
Registration: Jan 14, 2025

Sodium Chloride Physiological Solution

Approval Number: 国药准字H20253140
Registration: Jan 14, 2025

Oseltamivir Phosphate for Suspension

Approval Number: 国药准字H20253138
Registration: Jan 14, 2025

Compound α-Ketoacid Tablets

Approval Number: 国药准字H20253204
Registration: Jan 14, 2025

Oseltamivir Phosphate for Suspension

Approval Number: 国药准字H20253144
Registration: Jan 14, 2025

Methocarbamol Injection

Approval Number: 国药准字H20253181
Registration: Jan 14, 2025

Ibuprofen Sustained-release Capsules

Approval Number: 国药准字H20253196
Registration: Jan 14, 2025

Phloroglucinol Orally Disintegrating Tablets

Approval Number: 国药准字H20253135
Registration: Jan 14, 2025

Vortioxetine Hydrobromide Tablets

Approval Number: 国药准字H20253149
Registration: Jan 14, 2025

Sitagliptin Phosphate/metformin Hydrochloride Tablets

Approval Number: 国药准字H20253198
Registration: Jan 14, 2025

Lidocaine and Prilocaine Cream

Approval Number: 国药准字H20253151
Registration: Jan 14, 2025

Vortioxetine Hydrobromide Tablets

Approval Number: 国药准字H20253190
Registration: Jan 14, 2025

Vecuronium Bromide for Injection

Approval Number: 国药准字H20253159
Registration: Jan 14, 2025

Epalrestat Tablets

Approval Number: 国药准字H20253176
Registration: Jan 14, 2025

Ezetimibe Tablets

Approval Number: 国药准字H20253162
Registration: Jan 14, 2025

Sodium Hyaluronate Eye Drops

Approval Number: 国药准字H20253185
Registration: Jan 14, 2025

Tafluprost Eye Drops

Approval Number: 国药准字H20253164
Registration: Jan 14, 2025

Calcium Gluconate Injection

Approval Number: 国药准字H20253183
Registration: Jan 14, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.